Document complet  |  Dérouler chapitre  |  Etendre sommaire  |  Version HTML imprimable
Pharmaceuticals and the Internet Drug Regulatory Authorities' Perspective - Joint NLN-WHI Workshop, 24-25 September 2001
(2002; 80 pages) Voir le document au format PDF
Table des matières
Afficher le documentExecutive Summary
Afficher le documentOverview of activities by the World Health Organization - Dr Lembit Rägo
Afficher le documentOverview of activities by the Nordic Council on Medicines - Dr Ola Westbye
Ouvrir ce répertoire et afficher son contenuCountry Experiences
Afficher le documentThe Danish Consumer Council - Ms Margrethe Nielsen
Afficher le documentSwedish Industry Association - Dr Håkan Mandahl
Afficher le documentIntroduction to discussion points - Dr Lembit Rägo
Afficher le documentQuality aspects - Dr Ola Westbye
Afficher le documentPilot study on drug regulatory web sites: Current status and future challenges - Ms Elodie Jambert
Afficher le documentThe WHO model web site for drug regulatory authorities - Dr Lembit Rägo, Ms Elodie Jambert, Mr Jorg Hetzke
Afficher le documentConcluding discussion
Ouvrir ce répertoire et afficher son contenuAnnexes
Afficher le documentReferences
Afficher le documentBack cover
 

Pharmaceuticals and the Internet Drug Regulatory Authorities' Perspective - Joint NLN-WHI Workshop, 24-25 September 2001

24-25 September 2001, Copenhagen, Denmark

NLN Publication Number 56

WHO Library Cataloguing-in-Publication Data

Pharmaceuticals and the internet: drug regulatory authorities’ perspective

(NLN publication; no. 56)

Jointly published by the Nordic Council on Medicines (NLN) and the World Health Organization; includes the report of the NLN Conference 2001 on Pharmaceuticals and the Internet, 24-25 September 2001, organized in collaboration with the World Health Organization.

1. Legislation, Drug 2. Internet - standards 3. Drug and narcotic control - methods I. NLN Conference on Pharmaceuticals and the Internet (2001: Copenhagen, Denmark) II. Series

ISBN 92 4 159006 8

(NLM classification: QV 33)

The World Health Organization welcomes requests for permission to reproduce or translate its publications, in part or in full. Applications and enquiries should be addressed to the Office of Publications, World Health Organization, Geneva, Switzerland, which will be glad to provide the latest information on any changes made to the text, plans for new editions, and reprints and translations already available.

© World Health Organization 2002

Publications of the World Health Organization enjoy copyright protection in accordance with the provisions of Protocol 2 of the Universal Copyright Convention. All rights reserved.

The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the Secretariat of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries.

The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters.

Printed and bound in Malta by Interprint Limited

vers la section suivante
 
 
Le Portail d'information - Médicaments essentiels et produits de santé a été conçu et est maintenu par l'ONG Human Info. Dernière mise à jour: le 1 décembre 2019